'The Top Line': Panelists at Fierce's JPM Week event talk drug pricing policy, and Bayer's oncology head discusses cancer strategy

Fierce’s JPM Week event was packed full of informative panels, executive interviews and fireside chats. So, for today’s episode, we’ve pulled out a couple of snippets to take you inside the gathering.

First up, listen in on Fraiser Kansteiner’s lively panel discussion on how companies will keep their bottom lines strong while navigating the drug pricing policies the Biden administration rolled out just last year. You will also hear from Zoey Becker’s interview with Bayer’s Christine Roth. As head of the oncology strategic business unit, Roth talks about plans to establish Bayer as a strong competitor in the cancer space.

To learn more about topics in this episode:

To Listen to More Episodes from The Top Line